456 related articles for article (PubMed ID: 7472820)
1. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.
Wilschanski M; Zielenski J; Markiewicz D; Tsui LC; Corey M; Levison H; Durie PR
J Pediatr; 1995 Nov; 127(5):705-10. PubMed ID: 7472820
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
[TBL] [Abstract][Full Text] [Related]
3. Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results.
Desmarquest P; Feldmann D; Tamalat A; Boule M; Fauroux B; Tournier G; Clement A
Chest; 2000 Dec; 118(6):1591-7. PubMed ID: 11115444
[TBL] [Abstract][Full Text] [Related]
4. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
5. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
[TBL] [Abstract][Full Text] [Related]
7. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
[TBL] [Abstract][Full Text] [Related]
8. Correlation of sweat chloride concentration with genotypes in cystic fibrosis patients in Saguenay Lac-Saint-Jean, Quebec, Canada.
De Braekeleer M; Allard C; Leblanc JP; Aubin G; Simard F
Clin Biochem; 1998 Feb; 31(1):33-6. PubMed ID: 9559222
[TBL] [Abstract][Full Text] [Related]
9. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.
McKone EF; Velentgas P; Swenson AJ; Goss CH
J Cyst Fibros; 2015 Sep; 14(5):580-6. PubMed ID: 25660278
[TBL] [Abstract][Full Text] [Related]
10. Chloride and sodium ion concentrations in saliva and sweat as a method to diagnose cystic fibrosis.
Gonçalves AC; Marson FAL; Mendonça RMH; Bertuzzo CS; Paschoal IA; Ribeiro JD; Ribeiro AF; Levy CE
J Pediatr (Rio J); 2019; 95(4):443-450. PubMed ID: 29782810
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
Highsmith WE; Burch LH; Zhou Z; Olsen JC; Boat TE; Spock A; Gorvoy JD; Quittel L; Friedman KJ; Silverman LM
N Engl J Med; 1994 Oct; 331(15):974-80. PubMed ID: 7521937
[TBL] [Abstract][Full Text] [Related]
12. Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.
Durmowicz AG; Witzmann KA; Rosebraugh CJ; Chowdhury BA
Chest; 2013 Jan; 143(1):14-18. PubMed ID: 23276841
[TBL] [Abstract][Full Text] [Related]
13. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
Farrell PM; Koscik RE
Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
[TBL] [Abstract][Full Text] [Related]
14. The relationship between sweat chloride levels and mortality in cystic fibrosis varies by individual genotype.
Espel JC; Palac HL; Bharat A; Cullina J; Prickett M; Sala M; McColley SA; Jain M
J Cyst Fibros; 2018 Jan; 17(1):34-42. PubMed ID: 29221674
[TBL] [Abstract][Full Text] [Related]
15. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
[No Abstract] [Full Text] [Related]
16. Sweat chloride and immunoreactive trypsinogen in infants carrying two
Castellani C; Tridello G; Tamanini A; Assael BM
Arch Dis Child; 2017 Jul; 102(7):644-646. PubMed ID: 26755536
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children.
Lebecque P; Leal T; De Boeck C; Jaspers M; Cuppens H; Cassiman JJ
Am J Respir Crit Care Med; 2002 Mar; 165(6):757-61. PubMed ID: 11897640
[TBL] [Abstract][Full Text] [Related]
18. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency.
Sebro R; Levy H; Schneck K; Dimmock D; Raby BA; Cannon CL; Broeckel U; Risch NJ
Clin Genet; 2012 Dec; 82(6):546-51. PubMed ID: 22035343
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
